Cushing syndrome: reducing morbidity and mortality
نویسندگان
چکیده
منابع مشابه
VHRM-3389-reducing morbidity and mortality
Correspondence: Prakash Deedwania Chief, Cardiology Division, VACCHCS/ UCSF, 2615 e. Clinton Avenue, Fresno, CA 93703, USA email [email protected] Vibhuti Singh Clinical Assistant Professor of Medicine, Suncoast Cardiovascular Center, 601 7th Street South, St. Petersburg, FL 33701, USA [email protected] or [email protected] Abstract: Residual coronary heart disease remains a signi...
متن کاملMorbidity and Mortality of Iranian Patients with Hyper IgM Syndrome: a Clinical Analysis
Background: Defects in B cell class switch recombination (CSR) are a heterogeneous and yet very uncommon group of disorders which all have a genetic basis uniformly leading to hyper IgM (HIgM) syndrome. Due to the rare frequency of these conditions, a very small number of case series have been conducted on the affected patients. Objective: To shed some light on the morbidity and mortality regar...
متن کاملIs antenatal care effective in reducing maternal morbidity and mortality?
Women in developing countries are dying from simple preventable conditions but what impact can the procedures collectively called antenatal care having in reducing maternal mortality and morbidity? More importantly what is antenatal care? This review found that questions have been raised about the impact of antenatal care (specifically on maternal mortality) since its inception in developed cou...
متن کاملOn Reducing Mortality and Morbidity of Neonatal Surgical Care
Excellent survival of surgical neonates of western countries could not be duplicated in our region. One very important issue is our failure to maintain reproducible and objective records in our institutions. If we were able to do that more accurately, I fear that the figures of high morbidity and mortality will further rise. Here the commentary is not on sporadic and some selected institutions,...
متن کاملReducing morbidity and mortality in high risk patients with statins
Residual coronary heart disease remains a significant problem even after adequate statin therapy for cardiovascular risk reduction as currently recommended by the Adult Treatment Panel III (ATP-III) of the National Cholesterol Education Program (NCEP). This is particularly true for the high risk patients as defined by ATP-III that includes those patients who have a greater than 20% 10-year risk...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Sri Lanka Journal of Diabetes Endocrinology and Metabolism
سال: 2014
ISSN: 2012-998X
DOI: 10.4038/sjdem.v4i1.7239